Thus, given its frequency of inactivation in ccRCC, its critical role as a tumor suppressor, and its possible use as progression marker in ccRCC, effort have been placed to elucidate the biological consequences of SETD2 loss of function in ccRCC cells. The gene discussed is SETD2; the disease is nonpapillary renal cell carcinoma.